1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Short MW, Burgers KG and Fry VT:
Esophageal cancer. Am Fam Physician. 95:22–28. 2017.PubMed/NCBI
|
3
|
Daly JM, Fry WA, Little AG, Winchester DP,
McKee RF, Stewart AK and Fremgen AM: Esophageal cancer: Results of
an American college of surgeons patient care evaluation study. J Am
Coll Surg. 190:562–563. 2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Siewert JR, Stein HJ, Feith M, Bruecher
BL, Bartels H and Fink U: Histologic tumor type is an independent
prognostic parameter in esophageal cancer: Lessons from more than
1,000 consecutive resections at a single center in the Western
world. Ann Surg. 234:360–369. 2001. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rice TW, Apperson-Hansen C, DiPaola LM,
Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers
BM, Rusch VW, et al: Worldwide esophageal cancer collaboration:
Clinical staging data. Dis Esophagus. 29:707–714. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kaz AM and Grady WM: Epigenetic biomarkers
in esophageal cancer. Cancer Lett. 342:193–199. 2014. View Article : Google Scholar
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Cui J, Zhou B, Ross SA and Zempleni J:
Nutrition, microRNAs, and human health. Adv Nutr. 8:105–112. 2017.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
11
|
Feng QQ, Dong ZQ, Zhou Y, Zhang H and Long
C: miR-16-1-3 ptargets TWIST1 to inhibit cell proliferation and
invasion in NSCLC. Bratisl Lek Listy. 119:60–65. 2018.
|
12
|
Li H, Bian C, Liao L, Li J and Zhao RC:
miR-17-5p promotes human breast cancer cell migration and invasion
through suppression of HBP1. Breast Cancer Res Treat. 126:565–575.
2011. View Article : Google Scholar
|
13
|
Cun J and Yang Q: Bioinformatics-based
interaction analysis of miR-92a-3p and key genes in
tamoxifen-resistant breast cancer cells. Biomed Pharmacother.
107:117–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ke TW, Wei PL, Yeh KT, Chen WT and Cheng
YW: miR-92a promotes cell metastasis of colorectal cancer through
PTEN-Mediated PI3K/AKT pathway. Ann Surg Oncol. 22:2649–2655. 2015.
View Article : Google Scholar
|
15
|
Shen Y, Ding Y, Ma Q, Zhao L, Guo X, Shao
Y, Niu C, He Y, Zhang F, Zheng D, et al: Identification of novel
circulating MicroRNA biomarkers for the diagnosis of esophageal
squamous cell carcinoma and squamous dysplasia. Cancer Epidemiol
Biomarkers Prev. Apr 15–2019, Epub ahead of print. View Article : Google Scholar
|
16
|
Liu MX, Liao J, Xie M, Gao ZK, Wang XH,
Zhang Y, Shang MH, Yin LH, Pu YP and Liu R: miR-93-5p transferred
by exosomes promotes the proliferation of esophageal cancer cells
via inter-cellular communication by targeting PTEN. Biomed Environ
Sci. 31:171–185. 2018.PubMed/NCBI
|
17
|
Tullius BP, Shankar SP, Cole S, Triano V,
Aradhya S, Huang EC, Sanchez T and Pawar A: Novel heterozygous
mutation in the PTEN gene associated with ovarian germ cell tumor
complicated by growing teratoma syndrome and overgrowth in a
two-year-old female. Pediatr Blood Cancer. e277882019. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yan Y, Li Z, Zeng S, Wang X, Gong Z and Xu
Z: FGFR2-mediated phosphorylation of PTEN at tyrosine 240
contributes to the radioresistance of glioma. J Cell Commun Signal.
Apr 25–2019, Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhao MY, Wang LM, Liu J, Huang X, Liu J
and Zhang YF: miR-21 Suppresses Anoikis through targeting PDCD4 and
PTEN in human esophageal adenocarcinoma. Curr Med Sci. 38:245–251.
2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tutar L, Tutar E and Tutar Y: MicroRNAs
and cancer; an overview. Curr Pharm Biotechnol. 15:430–437. 2014.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
22
|
Jacobson MD, Weil M and Raff MC:
Programmed cell death in animal development. Cell. 88:347–354.
1997. View Article : Google Scholar : PubMed/NCBI
|
23
|
Fuchs Y and Steller H: Programmed cell
death in animal development and disease. Cell. 147:742–758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Tang HL, Tang HM, Mak KH, Hu S, Wang SS,
Wong KM, Wong CS, Wu HY, Law HT, Liu K, et al: Cell survival, DNA
damage, and oncogenic transformation after a transient and
reversible apoptotic response. Mol Biol Cell. 23:2240–2252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Joshi GN and Knecht DA: Multi-parametric
analysis of cell death pathways using live-cell microscopy. Curr
Protoc Toxicol. 58:Unit 4.40. 2013. View Article : Google Scholar
|
27
|
Dietrich JB: Apoptosis and anti-apoptosis
genes in the Bcl-2 family. Arch Physiol Biochem. 105:125–135.
1997.In French. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kvansakul M, Caria S and Hinds MG: The
Bcl-2 family in Host-Virus interactions. Viruses. 9:E2902017.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Crowley LC and Waterhouse NJ: Detecting
cleaved caspase-3 in apoptotic cells by flow cytometry. Cold Spring
Harbor Protocols. Nov 1–2016, Epub ahead of print. View Article : Google Scholar
|
30
|
Han T, Kang D, Ji D, Wang X, Zhan W, Fu M,
Xin HB and Wang JB: How does cancer cell metabolism affect tumor
migration and invasion? Cell Adh Migr. 7:395–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
32
|
Duff D and Long A: Roles for RACK1 in
cancer cell migration and invasion. Cell Signal. 35:250–255. 2017.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Tungsukruthai S, Sritularak B and
Chanvorachote P: Cycloarto-biloxanthone inhibits migration and
invasion of lung cancer cells. Anticancer Res. 37:6311–6319.
2017.PubMed/NCBI
|
34
|
Yang X, Xu Y, Wang T, Shu D, Guo P,
Miskimins K and Qian SY: Inhibition of cancer migration and
invasion by knocking down delta-5-desaturase in COX-2 overexpressed
cancer cells. Redox Biol. 11:653–662. 2017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhang N, Fu H, Song L, Ding Y, Wang X,
Zhao C and Zhao Y, Jiao F and Zhao Y: MicroRNA-100 promotes
migration and invasion through mammalian target of rapamycin in
esophageal squamous cell carcinoma. Oncol Rep. 32:1409–1418. 2014.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Steck PA, Pershouse MA, Jasser SA, Yung
WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T,
et al: Identification of a candidate tumour suppressor gene, MMAC1,
at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
38
|
Malaney P, Uversky VN and Davé V: PTEN
proteoforms in biology and disease. Cell Mol Life Sci.
74:2783–2794. 2017. View Article : Google Scholar : PubMed/NCBI
|
39
|
Guo H, German P, Bai S, Barnes S, Guo W,
Qi X, Lou H, Liang J, Jonasch E, Mills GB and Ding Z: The PI3K/AKT
pathway and renal cell carcinoma. J Genet Genomics. 42:343–353.
2015. View Article : Google Scholar : PubMed/NCBI
|
40
|
Chen H, Zhou L, Wu X, Li R, Wen J, Sha J
and Wen X: The PI3K/AKT pathway in the pathogenesis of prostate
cancer. Front Biosci (Landmark Ed). 21:1084–1091. 2016. View Article : Google Scholar
|
41
|
Mayer IA and Arteaga CL: The PI3K/AKT
pathway as a target for cancer treatment. Annu Rev Med. 67:11–28.
2016. View Article : Google Scholar
|
42
|
Yu M, Wang H, Xu Y, Yu D, Li D, Liu X and
Du W: Insulin-like growth factor-1 (IGF-1) promotes myoblast
proliferation and skeletal muscle growth of embryonic chickens via
the PI3K/Akt signalling pathway. Cell Biol Int. 39:910–922. 2015.
View Article : Google Scholar : PubMed/NCBI
|